Your choices go into the PDF (cover and captions); this bar does not.
Rebalix
Comparison report · official data side by side

JUSE vs JUIE


JUSEUS Equity Active UCITS ETF
IE000RSCXLM4 · Equity · United States
JUIEUS Research Enhanced Index Equity Active UCITS ETF
IE000W85O7M4 · Equity · United States
Open the interactive comparison on rebalix.com →

Comparison window: 15 Oct 20243 Sept 2026 (max: from the most recent launch) · currency: 🇪🇺 EUR · inflation: 🇮🇹 Italy · distributions: reinvested where declared

Report produced on 5 September 2026 · data as of the dates shown per section
Sources: official issuer documents (KID, factsheet, declared NAV series and holdings), ESMA register, ECB rates, Eurostat
Public methodology: rebalix.com/en/methodology

Informational document generated by rebalix.com — facts side by side, no recommendations. It does not constitute investment advice or investment research under Directive 2014/65/EU (MiFID II). Past performance is not indicative of future results.

RebalixJUSE vs JUIE · report of 5 September 2026

The funds at a glance

From official issuer documents and the ESMA register
JUSEIE000RSCXLM4US Equity Active UCITS ETFEquity · United States
Declared index
SPTR500N
TER
0.39%
Transaction (KID)
0.40%
Fund size
47 mln EUR
Launch
18 Jan 2024
Currency
USD
Replication
Gestione attiva (dal KID)
Hedging
No
Holdings
84
Effective 🇮🇹 rate
26.00%
JUIEIE000W85O7M4US Research Enhanced Index Equity Active UCITS ETFEquity · United States
Declared index
SPTR500N
TER
0.20%
Transaction (KID)
0.05%
Fund size
13.3 mld EUR
Launch
15 Oct 2024
Currency
EUR
Replication
Gestione attiva (dal KID)
Hedging
No
Holdings
253
Effective 🇮🇹 rate
26.00%

Tracking difference — year by year

Fund minus index, from issuer-declared series (complete calendar years). Each measures adherence to its OWN index.
JUSEn/d
not honestly computable
JUIEn/d
not honestly computable
Rebalix · JUSE vs JUIEsection 1 of 4
RebalixJUSE vs JUIE · report of 5 September 2026
JUSEUS Equity Active UCITS ETF · IE000RSCXLM4 · Equity · United States
JUIEUS Research Enhanced Index Equity Active UCITS ETF · IE000W85O7M4 · Equity · United States

Performance over the period, in euro

From 15 Oct 2024 to 3 Sept 2026 · base 100 · ECB rates, dividends reinvested where declared
In euro (nominal)
10012684118125
In today’s purchasing power (net of Italy inflation)
10012684115121
JUSEJUIE
Same scale in both panels: the gap between endpoints is Italian inflation over the period (Eurostat). Volatility stays nominal, as everywhere on the site.

How far they fell — drawdown from peak (nominal)

In euro · distance from the previous peak, day by day, on NAV: for distributing classes it includes ex-dividend drops (slightly deeper than total return)
0%-5%-10%-15%-20%-25%-30%JUSEJUIE20252026trough JUSE: −22.5% · 22 Apr 2025trough JUIE: −22.6% · 08 Apr 2025
Filled area: JUSE; thin lines: the other funds.
The worst episode, fund by fund
FundMax drawdownTroughRecovery timeUnderwater
JUSE−22.5%22 Apr 2025365 days454 days · back to break-even on 22 Apr 2026
JUIE−22.6%08 Apr 2025202 days277 days · back to break-even on 27 Oct 2025
"Recovery time" = the climb only: trough to break-even (0%). "Underwater" = decline + recovery: peak to break-even.

Drawdown net of Italy inflation

Same curve in purchasing-power terms: as on the site, drawdown follows the real view (volatility stays nominal, per methodology)
0%-5%-10%-15%-20%-25%-30%JUSEJUIE20252026trough JUSE: −24.1% · 22 Apr 2025trough JUIE: −24.1% · 08 Apr 2025
In real terms declines are deeper and recoveries slower. Monthly price index (Eurostat), held at the last published value.
Rebalix · JUSE vs JUIEsection 2 of 4
RebalixJUSE vs JUIE · report of 5 September 2026
JUSEUS Equity Active UCITS ETF · IE000RSCXLM4 · Equity · United States
JUIEUS Research Enhanced Index Equity Active UCITS ETF · IE000W85O7M4 · Equity · United States

Geographic composition

% of portfolio, from full declared holdings
JUSEJUIEUnited States94.6%95.7%Ireland3.2%3.3%Netherlands1.1%0.3%Canada0.7%0.0%Switzerland0.0%0.3%

Sector composition

GICS sectors, same sources and dates
JUSEJUIECash and/or Derivatives1.5%0.2%

Portfolio overlap

78 common holdings · ticker match on full official portfolios
25%50%75%100%Weight of common holdings in JUSE95.8%Weight of common holdings in JUIE67.6%Truly shared part (duplicated investment)64.9%
How the shared part is computed: for each security held by both funds, only the SMALLER of the two weights counts — a stock at 5% in one fund and 1% in the other overlaps by 1%, not 5%. Summed over all 78 common holdings this gives 64.9%: buying both funds, roughly this share of your money buys the same stocks twice. Matching uses the ISIN of each security, as published by both issuers in their baskets.
Rebalix · JUSE vs JUIEsection 3 of 4
RebalixJUSE vs JUIE · report of 5 September 2026

Full comparison table

"—" = not published by the source, never estimated
JUSEUS Equity Active UCITS ETF · IE000RSCXLM4 · Equity · United States
JUIEUS Research Enhanced Index Equity Active UCITS ETF · IE000W85O7M4 · Equity · United States
MetricJUSEJUIENote
Identity
CategoryEquity · United StatesEquity · United StatesRebalix engine classification
ReplicationGestione attiva (dal KID)Gestione attiva (dal KID)as declared by the issuer
Currency hedgingNoNosource: class name, factsheet
Income policyaccumulatingaccumulating
Costs
TER0.39%0.20%from the KID
Transaction costs (KID)0.40%0.05%internal
All-in cost0.79%0.25%TER + transaction
Tracking difference (3a)vs its OWN index
Performance in euro (ECB rates)
1 year+16.1%+21.5%
3 years
5 years
10 years— = series younger than the window
Risk · last 3 years
Volatility (ann.)
Max drawdown
Sharperisk-free = ECB MRO avg
Sortinolike Sharpe, downside only
Italian taxation
Effective capital-gains rate26.00%26.00%white list, current half-year
Documents & exchanges
Listing venues99ESMA register
Borsa Italiana tickerJUSEJUIE
Indicative cumulative cost: on 10,000 euro over 5 years (stated assumption: 5%/yr growth, cost = TER + transaction) ~495 euro JUSE · ~158 euro JUIE. Broker costs not included.

Disclaimer

This document is for information only and does not constitute investment advice under Directive 2014/65/EU (MiFID II), investment research, a personal recommendation, or an offer or solicitation to buy or sell financial instruments.

Past performance is not indicative of, nor a guarantee of, future results. The value of an investment can go down as well as up and investors may not get back the capital invested. Euro returns are affected by currency fluctuations.

Before any investment decision, read the KID and the Prospectus, available from the issuers. Tax treatment depends on individual circumstances and may change.

Data come from official issuer documents and public registers, following the public methodology at rebalix.com/en/methodology. "—" fields were not published by the source and have not been estimated. Rebalix receives no compensation from the issuers mentioned.

Rebalix · JUSE vs JUIEsection 4 of 4